Baby blood test could predict type 1 diabetes risk

NCT ID NCT07670143

Not yet recruiting Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to identify newborns with a high genetic risk of developing type 1 diabetes. Researchers will screen 50,000 infants using a simple genetic test to find those with a greater than 10% risk. The goal is not to treat diabetes, but to find eligible babies for future prevention trials that could stop the disease before it starts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this screening could identify at-risk infants early and help test ways to prevent type 1 diabetes before it starts.
What could go wrong: This is an observational study, not a treatment trial. It only identifies risk; it does not prevent or treat diabetes. Many screened infants may never develop the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

A. O. U. Maggiore della Carità di Novara

Novara, Novara, 28100, Italy
ASST Lecco - Ospedale Manzoni

Lecco, Lecco, 23900, Italy
Clinica Mangiagalli

Milan, Milano, 20122, Italy
IRCCS Ospedale San Raffaele

Milan, Milano, 20132, Italy
Ospedale Filippo Del Ponte

Varese, Varese, 21100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.